$2.54
-0.24-8.63%
In chiusura: -
$2.50
-0.04-1.57%
After hour: Oct 10, 7:59 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading BioXcel Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni BioXcel Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli BioXcel Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per BioXcel Therapeutics Inc
Numero di azioni emesse
19.647M
Azioni possedute dagli insider
217.499K
Percentuale posseduta dagli Insider
1.11%
Azioni possedute dagli investitori istituzionali
149.728B
Percentuale posseduta dagli investitori istituzionali
0.33%
Dec 17, 2024 | SEE REMARKS | 356.00 | $0.35 | -$58.13 | SELL-OPTIONS | 1.82% | 19.96K | Dec 14 - Dec 16 | ||
Dec 17, 2024 | CEO AND PRESIDENT | 2.99K | $0.36 | -$1.13K | SELL-OPTIONS | 0.04% | 7.75M | Dec 14 - Dec 16 | ||
Dec 17, 2024 | CHIEF FINANCIAL OFFICER | 506.00 | $0.36 | -$206.98 | SELL-OPTIONS | 2.48% | 20.93K | Dec 14 - Dec 16 | ||
Dec 17, 2024 | CHIEF SCIENTIFIC OFFICER | 653.00 | $0.35 | -$151.82 | SELL-OPTIONS | 2.31% | 28.93K | Dec 14 - Dec 16 | ||
Oct 03, 2024 | CHIEF COMMERCIAL OFFICER | 14.98K | $0.55 | -$3.45K | GRANT | 371.39% | 19.01K | Sep 17 - Oct 03 | ||
Oct 03, 2024 | SEE REMARKS | 14.39K | $0.55 | -$3.77K | GRANT | 153.33% | 23.77K | Sep 17 - Oct 03 | ||
Oct 03, 2024 | CHIEF SCIENTIFIC OFFICER | 14.07K | $0.55 | -$3.95K | GRANT | 99.10% | 28.28K | Sep 17 - Oct 03 | ||
Oct 03, 2024 | CHIEF FINANCIAL OFFICER | 14.07K | $0.55 | -$3.95K | GRANT | 226.87% | 20.28K | Sep 17 - Oct 03 | ||
Oct 03, 2024 | SEE REMARKS | 15.69K | $0.55 | -$3.06K | GRANT | 401.69% | 19.60K | Sep 17 - Oct 03 | ||
Sep 17, 2024 | CHIEF SCIENTIFIC OFFICER | 729.00 | $0.69 | -$244.70 | SELL-OPTIONS | 5.41% | 14.20K | Sep 14 - Sep 16 | ||
Sep 17, 2024 | CEO AND PRESIDENT | 4.13K | $0.69 | -$1.37K | SELL-OPTIONS | 0.05% | 7.74M | Sep 14 - Sep 16 | ||
Sep 17, 2024 | CHIEF FINANCIAL OFFICER | 728.00 | $0.69 | -$245.60 | SELL-OPTIONS | 13.29% | 6.20K | Sep 14 - Sep 16 | ||
Sep 17, 2024 | SEE REMARKS | 739.00 | $0.69 | -$238.05 | SELL-OPTIONS | 8.80% | 9.13K | Sep 14 - Sep 16 | ||
Sep 17, 2024 | SEE REMARKS | 383.00 | $0.69 | -$95.33 | SELL-OPTIONS | 10.87% | 3.91K | Sep 14 - Sep 16 | ||
Sep 17, 2024 | CHIEF COMMERCIAL OFFICER | 535.00 | $0.69 | -$148.52 | SELL-OPTIONS | 15.29% | 4.03K | Sep 15 - Sep 16 | ||
Jun 18, 2024 | CHIEF SCIENTIFIC OFFICER | 711.00 | $1.28 | -$476.16 | SELL-OPTIONS | 5.57% | 13.47K | Jun 14 - Jun 17 | ||
Jun 18, 2024 | CHIEF COMMERCIAL OFFICER | 506.00 | $1.26 | -$308.10 | SELL-OPTIONS | 16.91% | 3.50K | Jun 15 - Jun 17 | ||
Jun 18, 2024 | CHIEF FINANCIAL OFFICER | 711.00 | $1.26 | -$469.54 | SELL-OPTIONS | 14.92% | 5.48K | Jun 14 - Jun 17 | ||
Jun 18, 2024 | SEE REMARKS | 722.00 | $1.26 | -$456.02 | SELL-OPTIONS | 9.41% | 8.39K | Jun 14 - Jun 17 | ||
Jun 18, 2024 | SEE REMARKS | 366.00 | $1.28 | -$199.17 | SELL-OPTIONS | 11.59% | 3.52K | Jun 14 - Jun 17 | ||
Jun 18, 2024 | CEO AND PRESIDENT | 3.98K | $1.28 | -$2.74K | SELL-OPTIONS | 0.05% | 7.73M | Jun 14 - Jun 17 | ||
Jun 06, 2024 | CEO AND PRESIDENT | -1.43M | $1.61 | -$405.14K | SELL | -15.66% | 7.69M | Jun 04 - Jun 05 | ||
Apr 08, 2024 | SEE REMARKS | 2.61K | $2.62 | -$432.48 | SELL-OPTIONS | 93.00% | 5.41K | Mar 14 - Apr 04 | ||
Apr 08, 2024 | CEO AND PRESIDENT | 11.34K | $2.62 | -$13.82K | SELL-OPTIONS | 0.13% | 8.59M | Mar 14 - Apr 04 | ||
Apr 08, 2024 | CHIEF FINANCIAL OFFICER | 1.70K | $2.63 | -$2.82K | SELL-OPTIONS | 55.57% | 4.76K | Mar 14 - Apr 04 | ||
Apr 08, 2024 | CHIEF COMMERCIAL OFFICER | 1.99K | $2.64 | -$2.66K | SELL-OPTIONS | 199.20% | 2.99K | Mar 15 - Apr 04 | ||
Apr 08, 2024 | SEE REMARKS | 1.76K | $2.64 | -$2.67K | SELL-OPTIONS | 29.75% | 7.67K | Mar 14 - Apr 04 | ||
Apr 08, 2024 | CHIEF SCIENTIFIC OFFICER | 1.70K | $2.63 | -$2.81K | SELL-OPTIONS | 15.41% | 12.76K | Mar 14 - Apr 04 | ||
Jun 16, 2023 | CEO AND PRESIDENT | 2.61K | $10.64 | -$1.23M | SELL-OPTIONS | 6.64% | 41.90K | Jun 14 - Jun 16 | ||
May 24, 2023 | CEO AND PRESIDENT | -6.50K | $25.79 | -$167.64K | SELL | -14.19% | 39.29K | May 22 | ||
May 16, 2023 | CHIEF FINANCIAL OFFICER | 0.00 | $27.17 | -$135.86K | SELL-OPTIONS | 0.00% | 1.50K | May 14 - May 15 | ||
May 16, 2023 | SEE REMARKS | 3.21K | $27.32 | -$48.76K | SELL-OPTIONS | 283.26% | 4.35K | May 14 - May 15 | ||
Apr 10, 2023 | DIRECTOR | 0.00 | $8.87 | -$1.01M | SELL-OPTIONS | 0.00% | 8.55M | Apr 06 | ||
Mar 22, 2023 | CEO AND PRESIDENT | -4.50K | $9.69 | -$1.20M | SELL | -20.09% | 17.89K | Mar 20 - Mar 21 | ||
Mar 16, 2023 | CHIEF FINANCIAL OFFICER | 0.00 | $19.50 | -$40.64K | SELL-OPTIONS | 0.00% | 1.50K | Mar 14 - Mar 15 | ||
Mar 16, 2023 | CHIEF SCIENTIFIC OFFICER | 1.10K | $19.69 | -$19.40K | SELL-OPTIONS | 13.09% | 9.50K | Mar 14 - Mar 15 | ||
Mar 16, 2023 | CHIEF MEDICAL OFFICER | 1.24K | $19.70 | -$16.64K | SELL-OPTIONS | ∞ | 1.24K | Mar 14 - Mar 15 | ||
Mar 16, 2023 | SEE REMARKS | 1.13K | $19.63 | -$18.64K | SELL-OPTIONS | 113400.00% | 1.14K | Mar 14 - Mar 15 | ||
Jan 24, 2023 | CHIEF SCIENTIFIC OFFICER | -50.00K | $30.00 | -$1.50M | SELL | -85.62% | 8.40K | Jan 20 | ||
Jan 24, 2023 | CHIEF MEDICAL OFFICER | 0.00 | $15.21 | -$879.21K | SELL-OPTIONS | 0.00% | 0.00 | Jan 20 | ||
Jan 06, 2023 | DIRECTOR | 0.00 | $11.21 | -$1.30M | SELL-OPTIONS | 0.00% | 8.55M | Jan 04 - Jan 05 | ||
Dec 19, 2022 | CEO AND PRESIDENT | 0.00 | $10.05 | -$1.16M | SELL-OPTIONS | 0.00% | 11.96K | Dec 15 - Dec 16 | ||
Nov 14, 2022 | DIRECTOR | 0.00 | $7.71 | -$875.40K | SELL-OPTIONS | 0.00% | 8.55M | Nov 10 - Nov 11 | ||
Jun 29, 2021 | CEO, PRESIDENT AND SECRETARY | -473.25K | $30.83 | -$14.59M | SELL | -5.24% | 8.56M | Jun 25 | ||
Jun 29, 2021 | DIRECTOR | -473.25K | $30.83 | -$14.59M | SELL | -5.25% | 8.55M | Jun 25 | ||
Jun 29, 2021 | 10% OWNER | -473.25K | $30.83 | -$14.59M | SELL | -5.25% | 8.55M | Jun 25 | ||
Jun 29, 2021 | 10% OWNER | -473.25K | $30.83 | -$14.59M | SELL | -5.25% | 8.55M | Jun 25 | ||
Mar 17, 2021 | CHIEF SCIENTIFIC OFFICER | -15.00K | $48.50 | -$727.57K | SELL | -20.44% | 58.40K | Mar 15 | ||
Feb 19, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $30.11 | -$1.27M | SELL-OPTIONS | 0.00% | 0.00 | Feb 17 | ||
Feb 18, 2021 | CHIEF SCIENTIFIC OFFICER | -15.00K | $57.68 | -$865.15K | SELL | -16.97% | 73.40K | Feb 16 | ||
Feb 16, 2021 | CEO, PRESIDENT AND SECRETARY | -78.00K | $60.15 | -$4.84M | DISPOSITION | -49.37% | 80.00K | Mar 12 - Jul 24 | ||
Feb 03, 2021 | CHIEF FINANCIAL OFFICER | 0.00 | $26.85 | -$159.75K | SELL-OPTIONS | 0.00% | 1.50K | Feb 01 | ||
Jan 27, 2021 | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.40 | -$719.66K | SELL-OPTIONS | 0.00% | 88.40K | Jan 25 | ||
Jan 21, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $24.94 | -$1.23M | SELL-OPTIONS | 0.00% | 0.00 | Jan 19 | ||
Dec 30, 2020 | — | 0.00 | $25.93 | -$1.28M | OPTION EXERCISE | 0.00% | 0.00 | Dec 28 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.